Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2719 results

Sort By:

Early Identification of Children With Asthma

Study ID: NCT06988358
Start Date: 2025-12-30
End Date: 2027-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Group of children identified by the algorithm as having asthma

Group of children not identified by the algorithm as having asthma

Sponsor

University Hospital, Rouen

Source: clinicaltrials.gov

Share:
Add to list

Clinical Trials to Evaluate Metformin to Treat Depression in People Living With HIV

Study ID: NCT07007221
Start Date: 2026-01-01
End Date: 2030-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

600

Intervention / Treatment

Metformin

Metformin

Metformin

Placebo

Metformin

Fluoxetine

Metformin+Fluoxetine

double placebo

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

Study ID: NCT07146906
Start Date: 2025-11-18
End Date: 2030-07-16
Study Type

Interventional

Study Phase

Phase2

No. of Participants

32

Intervention / Treatment

zigakibart

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease

Study ID: NCT07078955
Start Date: 2025-12
End Date: 2027-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

99

Intervention / Treatment

BRM421 Ophthalmic Solution, 0.03%

Artificial Tear

BRM421 Ophthalmic Solution, 0.06%

Sponsor

BRIM Biotechnology Inc.

Source: clinicaltrials.gov

Share:
Add to list

Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children

Study ID: NCT07222943
Start Date: 2025-12-01
End Date: 2026-11-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment

Guided Imagery Therapy

Sponsor

Baylor College of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Immersive Physical Therapy in the Neonatal Intensive Care Unit (NICU)

Study ID: NCT06927037
Start Date: 2026-01
End Date: 2027-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment
Sponsor

University of North Carolina, Chapel Hill

Source: clinicaltrials.gov

Share:
Add to list

Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach

Study ID: NCT07152184
Start Date: 2026-01-01
End Date: 2032-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

288

Intervention / Treatment

Use of antipsychotic treatment with marketing authorization at doses lower than those recommended: - Olanzapine - Zuclopenthixol - Risperidone - Pipotiazine palmitate / Pipotiazine - Quetiapine - Flup

Sponsor

University Hospital, Strasbourg, France

Source: clinicaltrials.gov

Share:
Add to list

Intraoperative Optical Coherence Tomography for Ophthalmic Surgical Guidance - Cornea

Study ID: NCT05210478
Start Date: 2026-01
End Date: 2030-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Optical coherence tomography (OCT)

Sponsor

Vanderbilt University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

Study ID: NCT06860815
Start Date: 2025-12-12
End Date: 2027-01-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

11

Intervention / Treatment

Biopsy

Biospecimen Collection

Cemiplimab

Computed Tomography

Magnetic Resonance Imaging

Transarterial Radioembolization

Yttrium Y 90 Resin Microspheres

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function

Study ID: NCT07169825
Start Date: 2026-02-13
End Date: 2028-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Lu-177

SPECT

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list